Trade Semler Scientific Inc - SMLR CFD

Semler Scientific, Inc. Company profile

About Semler Scientific Inc

Semler Scientific, Inc. provides technology solutions to healthcare providers. The Company develops, manufactures and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular-testing product, QuantaFlo, which measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease, or PAD. QuantaFlo is an approximately four-minute in-office blood flow test. The healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger much like pulse oximetry devices. It has placed its QuantaFlo product with healthcare insurance plans, integrated delivery networks, independent physician groups and companies contracting with the healthcare industry, such as risk assessment groups.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Semler Scientific Inc revenues increased 37% to $53M. Net income increased 23% to $17.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Sales and marketing increase of 44% to $14.3M (expense), General and administrative increase of 40% to $8.6M (expense).